Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands First Genio implants successfully ...

There is no cure for the rare disease Hereditary Spastic Paraplegia (HSP), but researchers from Drexel University’s College ...

Apyron, Inc. is a medical technology company with a product portfolio designed to address chronic pain and joint-related disorders, with a core value to restore mobility in patients and provide them ...

There is no cure for the rare disease Hereditary Spastic Paraplegia (HSP), but researchers from Drexel University's College ...

Mainstay Medical Holdings plc today announced that the International Society for the Advancement of Spine Surgery (ISASS) has issued recommendations and coverage criteria for the use of restorative ...

LOS ANGELES, CA / ACCESS Newswire / November 19, 2025 / Elle Communications, a subsidiary of Dolphin (NASDAQ:DLPN), is the agency of record for NET Recovery, an FDA-cleared neurostimulation device 1 ...

One of the most common causes of epilepsy is a structural brain abnormality. “Epilepsy can result from structural issues in ...

FDA feedback provides clear framework for Nexalin’s planned U.S. Pilot Study and supports a potential De Novo pathway for the ...

OverviewThe global neurotech devices market is experiencing strong momentum and is projected to grow at a CAGR of approximately 13% over the forecast period. This growth trajectory is shaped by ...